Avid Bioservices

Avid Bioservices is a dedicated CDMO specialising in the development and CGMP manufacturing of biologics for the biotechnology, biopharmaceutical, and cell and gene therapy industries.

Established in 1993 as Peregrine Pharmaceuticals, Avid Bioservices has evolved over the years to become an independent, publicly traded entity (NASDAQ: CDMO) since 2018. With over three decades of experience, the company offers comprehensive services ranging from early-stage process development to full-scale commercial manufacturing. Their state-of-the-art facilities in Orange County, California, are equipped for both stainless steel and single-use production, ensuring flexibility and adherence to the highest quality standards.

Key Products and Services

• Mammalian Protein Development & Manufacturing Services: Avid provides end-to-end solutions for biologics development, including upstream and downstream process development, analytical method development, CGMP clinical and commercial manufacturing, bulk packaging, release and stability testing, and regulatory submission support.
• Viral Vector Development & Manufacturing Services: Specialising in viral vector design and optimisation, Avid offers scalable production services tailored for gene therapy and vaccine applications

Avid Bioservices prides itself on its collaborative approach, technical expertise, and unwavering commitment to quality. The company's experienced team ensures transparent communication and superior customer service, aiming to exceed client expectations at every project stage. With recent expansions and a focus on innovation, Avid is well-positioned to support the evolving needs of the life sciences industry.